tooluniverse-gwas-study-explorer

Compare original and translation side by side

🇺🇸

Original

English

🇨🇳

Translation

Chinese

GWAS Study Deep Dive & Meta-Analysis

GWAS研究深度解析与元分析

Compare GWAS studies, perform meta-analyses, and assess replication across cohorts

对比GWAS研究、开展元分析并评估跨队列的重复性

Overview

概述

The GWAS Study Deep Dive & Meta-Analysis skill enables comprehensive comparison of genome-wide association studies (GWAS) for the same trait, meta-analysis of genetic loci across studies, and systematic assessment of replication and study quality. It integrates data from the NHGRI-EBI GWAS Catalog and Open Targets Genetics to provide a complete picture of the genetic architecture of complex traits.

GWAS研究深度解析与元分析Skill可对同一性状的全基因组关联研究（GWAS）进行全面对比，对跨研究的基因位点开展元分析，并系统性评估研究的重复性与质量。它整合了NHGRI-EBI GWAS Catalog和Open Targets Genetics的数据，为复杂性状的遗传结构提供完整视角。

Key Capabilities

核心功能

Study Comparison: Compare all GWAS studies for a trait, assessing sample sizes, ancestries, and platforms
Meta-Analysis: Aggregate effect sizes across studies and calculate heterogeneity statistics
Replication Assessment: Identify replicated vs novel findings across discovery and replication cohorts
Quality Evaluation: Assess statistical power, ancestry diversity, and data availability

研究对比：对比某一性状的所有GWAS研究，评估样本量、祖先群体及研究平台
元分析：整合跨研究的效应量并计算异质性统计量
重复性评估：识别发现队列与重复队列中的已验证结果和新发现
质量评估：评估统计效力、祖先多样性及数据可用性

Use Cases

应用场景

1. Comprehensive Trait Analysis

1. 全面性状分析

Scenario: "I want to understand all available GWAS data for type 2 diabetes"

Workflow:

Search for all T2D studies in GWAS Catalog
Filter by sample size and ancestry
Extract top associations from each study
Identify consistently replicated loci
Assess ancestry-specific effects

Outcome: Complete landscape of T2D genetics with replicated findings and population-specific signals

场景："我想了解2型糖尿病的所有可用GWAS数据"

流程:

在GWAS Catalog中搜索所有2型糖尿病（T2D）研究
按样本量和祖先群体筛选
提取每项研究的顶级关联结果
识别持续重复的基因位点
评估祖先特异性效应

结果：获得2型糖尿病遗传学的完整图景，包含已验证结果和群体特异性信号

2. Locus-Specific Meta-Analysis

2. 位点特异性元分析

Scenario: "Is the TCF7L2 association with T2D consistent across all studies?"

Workflow:

Retrieve all TCF7L2 (rs7903146) associations for T2D
Calculate combined effect size and p-value
Assess heterogeneity (I² statistic)
Generate forest plot data
Interpret heterogeneity level

Outcome: Quantitative assessment of effect size consistency with heterogeneity interpretation

场景："TCF7L2与2型糖尿病的关联在所有研究中是否一致？"

流程:

获取所有2型糖尿病研究中TCF7L2（rs7903146）的关联结果
计算合并效应量与p值
评估异质性（I²统计量）
生成森林图数据
解读异质性水平

结果：对效应量的一致性进行量化评估并解读异质性

3. Replication Analysis

3. 重复性分析

Scenario: "Which findings from the discovery cohort replicated in the independent sample?"

Workflow:

Get top hits from discovery study
Check for presence and significance in replication study
Assess direction consistency
Calculate replication rate
Identify novel vs failed replication

Outcome: Systematic replication report with success rates and failed findings

场景："发现队列中的哪些结果在独立样本中得到了重复验证？"

流程:

获取发现队列的顶级关联结果
检查这些结果在重复队列中的存在性与显著性
评估效应方向的一致性
计算重复率
识别新发现与未重复的结果

结果：系统性的重复验证报告，包含成功率与未重复的结果

4. Multi-Ancestry Comparison

4. 跨祖先群体对比

Scenario: "Are T2D loci consistent across European and East Asian populations?"

Workflow:

Filter studies by ancestry
Compare top associations between populations
Identify shared vs population-specific loci
Assess allele frequency differences
Evaluate transferability of genetic risk scores

Outcome: Ancestry-specific genetic architecture with transferability assessment

场景："2型糖尿病的基因位点在欧洲人群与东亚人群中是否一致？"

流程:

按祖先群体筛选研究
对比不同群体的顶级关联结果
识别共享位点与群体特异性位点
评估等位基因频率差异
评估遗传风险评分的可转移性

结果：具有祖先特异性的遗传结构及可转移性评估

Statistical Methods

统计方法

Meta-Analysis Approach

元分析方法

This skill implements standard GWAS meta-analysis methods:

Fixed-Effects Model:

Used when heterogeneity is low (I² < 25%)
Weights studies by inverse variance
Assumes true effect size is the same across studies

Random-Effects Model (recommended when I² > 50%):

Accounts for between-study variation
More conservative than fixed-effects
Better for diverse ancestries or methodologies

Heterogeneity Assessment:

The I² statistic measures the percentage of variance due to between-study heterogeneity:

I² = [(Q - df) / Q] × 100%

where Q = Cochran's Q statistic
      df = degrees of freedom (n_studies - 1)

Interpretation Guidelines:

I² < 25%: Low heterogeneity → fixed-effects appropriate
I² = 25-50%: Moderate heterogeneity → investigate sources
I² = 50-75%: Substantial heterogeneity → random-effects preferred
I² > 75%: Considerable heterogeneity → meta-analysis may not be appropriate

本Skill采用标准的GWAS元分析方法：

固定效应模型:

适用于异质性较低的情况（I² < 25%）
按逆方差对研究进行加权
假设各研究的真实效应量相同

随机效应模型（当I² > 50%时推荐使用）:

考虑研究间的变异
比固定效应模型更保守
更适用于祖先群体多样或研究方法不同的情况

异质性评估:

I²统计量用于衡量由研究间差异导致的变异百分比：

I² = [(Q - df) / Q] × 100%

其中 Q = Cochran's Q统计量
      df = 自由度（研究数量 - 1）

解读指南:

I² < 25%：低异质性 → 适合使用固定效应模型
I² = 25-50%：中等异质性 → 需调查异质性来源
I² = 50-75%：显著异质性 → 推荐使用随机效应模型
I² > 75%：高度异质性 → 元分析可能不适用

Sources of Heterogeneity

异质性来源

Common reasons for high I²:

Ancestry differences: Different allele frequencies and LD structure
Phenotype heterogeneity: Trait definition varies across studies
Platform differences: Imputation quality and coverage
Winner's curse: Discovery studies overestimate effect sizes
Cohort characteristics: Age, sex, environmental factors

Recommendations:

Perform subgroup analysis by ancestry
Use meta-regression to investigate sources
Consider excluding outlier studies
Apply genomic control correction

导致I²值较高的常见原因：

祖先群体差异：等位基因频率和连锁不平衡（LD）结构不同
表型异质性：不同研究的性状定义存在差异
平台差异：基因型填充质量与覆盖度不同
胜者诅咒：发现队列高估了效应量
队列特征：年龄、性别、环境因素不同

建议:

按祖先群体进行亚组分析
使用元回归调查异质性来源
考虑排除异常值研究
应用基因组控制校正

Study Quality Assessment

研究质量评估

Quality Metrics

质量指标

The skill evaluates studies based on:

1. Sample Size:

Power to detect associations (80% power requires n > 10,000 for OR=1.2)
Precision of effect size estimates
Ability to detect modest effects

2. Ancestry Diversity:

Single-ancestry vs multi-ancestry
Population stratification control
Transferability of findings

3. Data Availability:

Summary statistics available for meta-analysis
Individual-level data vs summary-level
Imputation quality scores

4. Genotyping Quality:

Platform density and coverage
Imputation reference panel
Quality control measures

5. Statistical Rigor:

Genome-wide significance threshold (p < 5×10⁻⁸)
Multiple testing correction
Replication in independent cohort

本Skill从以下维度评估研究质量：

1. 样本量:

检测关联的效力（对于OR=1.2的变异，需样本量n > 10000才能达到80%的统计效力）
效应量估计的精度
检测中等效应变异的能力

2. 祖先多样性:

单祖先群体 vs 多祖先群体
群体分层控制
研究结果的可转移性

3. 数据可用性:

可用于元分析的汇总统计数据
个体水平数据 vs 汇总水平数据
基因型填充质量评分

4. 基因分型质量:

研究平台的密度与覆盖度
基因型填充参考面板
质量控制措施

5. 统计严谨性:

全基因组显著性阈值（p < 5×10⁻⁸）
多重检验校正
在独立队列中的重复验证

Quality Tiers

质量等级

Tier 1 (High Quality):

n ≥ 50,000
Summary statistics available
Multi-ancestry or large single-ancestry
Imputed to high-quality reference
Independent replication

Tier 2 (Moderate Quality):

n ≥ 10,000
Standard GWAS platform
Adequate power for common variants
Some data availability

Tier 3 (Limited):

n < 10,000
Limited power
May miss modest effects
Use with caution

1级（高质量）:

n ≥ 50000
可获取汇总统计数据
多祖先群体或大样本单祖先群体
基于高质量参考面板进行基因型填充
经过独立队列重复验证

2级（中等质量）:

n ≥ 10000
使用标准GWAS平台
对常见变异具有足够统计效力
具备一定的数据可用性

3级（有限质量）:

n < 10000
统计效力有限
可能遗漏中等效应的变异
需谨慎使用

Best Practices

最佳实践

Before Meta-Analysis

元分析前的准备

Check phenotype consistency: Ensure studies measure the same trait
Verify ancestry overlap: High heterogeneity expected if ancestries differ
Harmonize alleles: Align effect alleles across studies
Quality control: Exclude low-quality studies or associations

检查表型一致性：确保各研究测量的是同一性状
验证祖先群体重叠情况：若祖先群体不同，预计会出现较高异质性
等位基因 harmonization：统一各研究的效应等位基因
质量控制：排除低质量研究或关联结果

Interpreting Results

结果解读

Genome-wide significance: p < 5×10⁻⁸ (Bonferroni for ~1M independent tests)
Replication threshold: p < 0.05 in independent cohort
Direction consistency: Effect should be same direction across studies
Heterogeneity: I² > 50% suggests caution in interpretation

全基因组显著性：p < 5×10⁻⁸（针对约100万次独立检验的Bonferroni校正阈值）
重复验证阈值：在独立队列中p < 0.05
效应方向一致性：各研究的效应方向应一致
异质性：I² > 50%时，解读结果需谨慎

Common Pitfalls

常见误区

❌ Don't:

Meta-analyze without checking heterogeneity
Ignore ancestry differences
Over-interpret nominal p-values
Assume replication failure means false positive

✅ Do:

Always report I² statistic
Perform sensitivity analyses
Consider ancestry-stratified analysis
Account for winner's curse in discovery studies

❌ 请勿:

未检查异质性就开展元分析
忽略祖先群体差异
过度解读名义p值
假设重复验证失败就意味着假阳性

✅ 建议:

始终报告I²统计量
进行敏感性分析
考虑按祖先群体分层分析
考虑发现队列中的胜者诅咒效应

Limitations & Caveats

局限性与注意事项

Data Limitations

数据局限性

Incomplete Overlap: Studies may analyze different SNPs
Cohort Overlap: Some cohorts participate in multiple studies (inflates significance)
Publication Bias: Significant findings more likely to be published
Winner's Curse: Discovery studies overestimate effect sizes
Imputation Quality: Varies across studies and populations

重叠不完全：各研究可能分析不同的SNP
队列重叠：部分队列参与了多项研究（会夸大显著性）
发表偏倚：显著结果更易被发表
胜者诅咒：发现队列高估了效应量
基因型填充质量：不同研究和群体间存在差异

Statistical Limitations

统计局限性

Heterogeneity: High I² may preclude meaningful meta-analysis
Sample Size Differences: Large studies dominate fixed-effects models
Allele Frequency Differences: Same variant has different effects across ancestries
Linkage Disequilibrium: Fine-mapping needed to identify causal variants
Gene-Environment Interactions: Not captured in standard meta-analysis

异质性：高I²值可能导致元分析结果无意义
样本量差异：大样本研究会主导固定效应模型的结果
等位基因频率差异：同一变异在不同祖先群体中的效应不同
连锁不平衡：需通过精细定位识别因果变异
基因-环境交互作用：标准元分析无法捕捉此类交互作用

Interpretation Guidelines

解读指南

When I² > 75%:

Meta-analysis results should be interpreted with extreme caution
Investigate sources of heterogeneity systematically
Consider ancestry-specific or subgroup analyses
Descriptive comparison may be more appropriate than meta-analysis

When Studies Conflict:

Check for methodological differences
Verify phenotype definitions match
Investigate population stratification
Consider conditional analysis

当I² > 75%时:

元分析结果需极其谨慎地解读
系统性调查异质性来源
考虑按祖先群体或亚组进行分析
描述性对比可能比元分析更合适

当研究结果存在冲突时:

检查研究方法的差异
验证表型定义是否一致
调查群体分层情况
考虑条件分析

Scientific References

科学参考文献

Key Publications

关键出版物

GWAS Best Practices:
- Visscher et al. (2017). "10 Years of GWAS Discovery" American Journal of Human Genetics 101(1): 5-22
- PMID: 28686856
- DOI: 10.1016/j.ajhg.2017.06.005
Meta-Analysis Methods:
- Evangelou & Ioannidis (2013). "Meta-analysis methods for genome-wide association studies and beyond" Nature Reviews Genetics 14: 379-389
- PMID: 23657481
Heterogeneity Interpretation:
- Higgins et al. (2003). "Measuring inconsistency in meta-analyses" BMJ 327: 557-560
- PMID: 12958120
Multi-Ancestry GWAS:
- Peterson et al. (2019). "Genome-wide Association Studies in Ancestrally Diverse Populations" Nature Reviews Genetics 20: 409-422
- PMID: 30926972
Replication Standards:
- Chanock et al. (2007). "Replicating genotype-phenotype associations" Nature 447: 655-660
- PMID: 17554299

GWAS最佳实践:
- Visscher等人（2017）。"10 Years of GWAS Discovery" American Journal of Human Genetics 101(1): 5-22
- PMID: 28686856
元分析方法:
- Evangelou & Ioannidis（2013）。"Meta-analysis methods for genome-wide association studies and beyond" Nature Reviews Genetics 14: 379-389
- PMID: 23657481
异质性解读:
- Higgins等人（2003）。"Measuring inconsistency in meta-analyses" BMJ 327: 557-560
- PMID: 12958120
多祖先群体GWAS:
- Peterson等人（2019）。"Genome-wide Association Studies in Ancestrally Diverse Populations" Nature Reviews Genetics 20: 409-422
- PMID: 30926972
重复验证标准:
- Chanock等人（2007）。"Replicating genotype-phenotype associations" Nature 447: 655-660
- PMID: 17554299

Tools Used

使用工具

GWAS Catalog API

```
gwas_search_studies
```
: Find studies by trait
```
gwas_get_study_by_id
```
: Get detailed study metadata
```
gwas_get_associations_for_study
```
: Retrieve study associations
```
gwas_get_associations_for_snp
```
: Get SNP associations across studies
```
gwas_search_associations
```
: Search associations by trait

```
gwas_search_studies
```
: 按性状查找研究
```
gwas_get_study_by_id
```
: 获取详细研究元数据
```
gwas_get_associations_for_study
```
: 提取研究的关联结果
```
gwas_get_associations_for_snp
```
: 获取跨研究的SNP关联结果
```
gwas_search_associations
```
: 按性状搜索关联结果

Open Targets Genetics GraphQL API

OpenTargets_search_gwas_studies_by_disease

: Disease-based study search

```
OpenTargets_get_gwas_study
```
: Detailed study information with LD populations
```
OpenTargets_get_variant_credible_sets
```
: Fine-mapped loci for variant
```
OpenTargets_get_study_credible_sets
```
: All credible sets for study
```
OpenTargets_get_variant_info
```
: Variant annotation and allele frequencies

OpenTargets_search_gwas_studies_by_disease

: 基于疾病的研究搜索

```
OpenTargets_get_gwas_study
```
: 包含LD群体的详细研究信息
```
OpenTargets_get_variant_credible_sets
```
: 变异的精细定位位点
```
OpenTargets_get_study_credible_sets
```
: 研究的所有精细定位位点
```
OpenTargets_get_variant_info
```
: 变异注释与等位基因频率

Glossary

术语表

Association: Statistical relationship between a genetic variant and a trait

Credible Set: Set of variants likely to contain the causal variant (from fine-mapping)

Effect Size: Magnitude of genetic association (beta coefficient or odds ratio)

Fine-Mapping: Statistical method to identify causal variants within a locus

Genome-Wide Significance: p < 5×10⁻⁸, accounting for ~1M independent tests

Heterogeneity (I²): Percentage of variance due to between-study differences

L2G (Locus-to-Gene): Score predicting which gene is affected by a GWAS locus

LD (Linkage Disequilibrium): Non-random association of alleles at different loci

Meta-Analysis: Statistical combination of results from multiple studies

Replication: Independent confirmation of an association in a new cohort

Summary Statistics: Per-SNP statistics (p-value, beta, SE) from GWAS

Winner's Curse: Overestimation of effect size in discovery studies

Association（关联）: 遗传变异与性状之间的统计关系

Credible Set（可信集）: 可能包含因果变异的一组变异（来自精细定位）

Effect Size（效应量）: 遗传关联的强度（β系数或比值比）

Fine-Mapping（精细定位）: 识别某一位点内因果变异的统计方法

Genome-Wide Significance（全基因组显著性）: p < 5×10⁻⁸，针对约100万次独立检验的校正阈值

Heterogeneity (I²)（异质性）: 由研究间差异导致的变异百分比

L2G (Locus-to-Gene)（位点-基因评分）: 预测GWAS位点影响的基因的评分

LD (Linkage Disequilibrium)（连锁不平衡）: 不同位点等位基因的非随机关联

Meta-Analysis（元分析）: 对多项研究结果进行统计合并的方法

Replication（重复验证）: 在新队列中独立验证某一关联结果

Summary Statistics（汇总统计数据）: GWAS中每个SNP的统计数据（p值、β系数、标准误）

Winner's Curse（胜者诅咒）: 发现队列中对效应量的高估

Next Steps

后续步骤

After running this skill, consider:

Fine-Mapping: Use credible sets from Open Targets to identify causal variants
Functional Follow-Up: Investigate biological mechanisms of replicated loci
Genetic Risk Scores: Calculate polygenic risk scores using validated loci
Drug Target Identification: Use L2G scores to prioritize therapeutic targets
Cross-Trait Analysis: Look for pleiotropy with related traits

运行本Skill后，可考虑：

精细定位: 使用Open Targets的可信集识别因果变异
功能验证: 探索已验证位点的生物学机制
遗传风险评分: 使用经过验证的位点计算多基因风险评分
药物靶点识别: 利用L2G评分优先选择治疗靶点
跨性状分析: 寻找与相关性状的多效性关联

Version History

版本历史

v1.0 (2026-02-13): Initial release with study comparison, meta-analysis, and replication assessment

Created by: ToolUniverse GWAS Analysis Team Last Updated: 2026-02-13 License: Open source (MIT)

v1.0 (2026-02-13): 初始版本，包含研究对比、元分析及重复性评估功能

创建者: ToolUniverse GWAS分析团队 最后更新: 2026-02-13 许可证: 开源（MIT）